- Home
- CMPS vs ZH Comparison
CMPS vs ZH Comparison
Compare CMPS & ZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- ZH
- Stock Information
- Founded
- CMPS 2020
- ZH 2011
- Country
- CMPS United Kingdom
- ZH China
- Employees
- CMPS N/A
- ZH N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- ZH Business Services
- Sector
- CMPS Health Care
- ZH Consumer Discretionary
- Exchange
- CMPS Nasdaq
- ZH Nasdaq
- Market Cap
- CMPS 364.9M
- ZH 352.6M
- IPO Year
- CMPS 2020
- ZH 2021
- Fundamental
- Price
- CMPS $4.33
- ZH $4.18
- Analyst Decision
- CMPS Strong Buy
- ZH Strong Buy
- Analyst Count
- CMPS 7
- ZH 1
- Target Price
- CMPS $17.83
- ZH $4.70
- AVG Volume (30 Days)
- CMPS 2.3M
- ZH 303.1K
- Earning Date
- CMPS 07-31-2025
- ZH 08-21-2025
- Dividend Yield
- CMPS N/A
- ZH N/A
- EPS Growth
- CMPS N/A
- ZH N/A
- EPS
- CMPS N/A
- ZH N/A
- Revenue
- CMPS N/A
- ZH $464,095,225.00
- Revenue This Year
- CMPS N/A
- ZH N/A
- Revenue Next Year
- CMPS N/A
- ZH $7.46
- P/E Ratio
- CMPS N/A
- ZH N/A
- Revenue Growth
- CMPS N/A
- ZH N/A
- 52 Week Low
- CMPS $2.25
- ZH $3.01
- 52 Week High
- CMPS $8.54
- ZH $6.32
- Technical
- Relative Strength Index (RSI)
- CMPS 54.36
- ZH 42.01
- Support Level
- CMPS $3.92
- ZH $4.58
- Resistance Level
- CMPS $4.78
- ZH $4.95
- Average True Range (ATR)
- CMPS 0.35
- ZH 0.18
- MACD
- CMPS 0.02
- ZH -0.08
- Stochastic Oscillator
- CMPS 57.81
- ZH 7.59
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About ZH Zhihu Inc. (every two of each representing one ordinary share)
Zhihu Inc is predominantly engaged in the operation of one online content community and monetizes through paid membership services, advertising services, content-commerce solutions services, and vocational training in China. It generates revenues from Advertising services, Paid membership services, Content-commerce solutions, and Others. It derives all its revenues within China.